ÂÜÀòÂÒÂ×

Greg Bokar is Executive Vice President and General Counsel of Sunovion Pharmaceuticals Inc., a global biopharmaceutical company with over 1,600 employees focused on the innovative application of science and medicine to help people with serious medical conditions.

Mr. Bokar provides leadership for all aspects of the Legal Affairs function and serves as a member of the company’s Executive Leadership Team. He is also a member of the Executive Officer's Committee of Sumitomo Dainippon Pharma America (SDPA), an affiliate of Sunovion.

He joined Sunovion in 2015 with significant domestic and international legal experience in transactions, corporate matters, governance, intellectual property, litigation, HR, insurance, compliance and M&A.

Previously Mr. Bokar served as Chief Legal Officer for Elan Pharmaceuticals LLC U.S., where he provided legal counsel for Elan’s global biopharmaceutical business and managed both a domestic and international legal team. Earlier in his career, Mr. Bokar worked as a Senior Attorney with Argonne National Laboratories in Argonne, IL and as Associate Counsel with the U.S. Navy in China Lake, CA.

Mr. Bokar holds a B.S. degree in Chemistry, an M.B.A. from Cleveland State University and a J.D. from Thomas M. Cooley Law School. A licensed attorney in four states, he also is a registered patent lawyer, licensed to practice before the U.S. Patent and Trademark Office.